Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionMackenzie Financial Corp
Latest Disclosed Ownership1,017,219 shares
Latest Disclosed Value $ 141,769,812
Mackenzie Financial Corp ownership in GILD / Gilead Sciences, Inc.

On May 13, 2026 - Mackenzie Financial Corp filed a 13F-HR form disclosing ownership of 1,017,219 shares of Gilead Sciences, Inc. (CH:GILD) valued at $141,769,812 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 18, 2026 disclosing 1,778,545 shares of Gilead Sciences, Inc.. This represents a change in shares of -42.81% during the quarter.

Mackenzie Financial Corp has a history of taking positions in derivatives of the underlying security (GILD) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CH:GILD / Gilead Sciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F GILEAD SCIENCES COM 375558103 1,017,219 -761,326 -42.81 141,770 -35.16 0.1701
2026-02-18 2025-12-31 13F GILEAD SCIENCES COM 375558103 1,778,545 -285,379 -13.83 218,650 -4.56 0.2590
2025-11-13 2025-09-30 13F GILEAD SCIENCES COM 375558103 2,063,924 -464,125 -18.36 229,096 -18.26 0.2775
2025-08-13 2025-06-30 13F GILEAD SCIENCES COM 375558103 2,528,049 27,840 1.11 280,285 0.05 0.3631
2025-05-07 2025-03-31 13F GILEAD SCIENCES COM 375558103 2,500,209 1,939,273 345.72 280,148 440.69 0.3983
2025-05-02 2024-12-31 13F/A-2 GILEAD SCIENCES COM 375558103 560,936 -45,294 -7.47 51,814 1.94 0.0706
2025-02-20 2024-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 560,936 -45,294 51,814 0.0673
2025-02-14 2024-12-31 13F Gilead Sciences Common Stock 375558103 560,936 -45,294 51,436 0.0738
2024-11-13 2024-09-30 13F GILEAD SCIENCES COM 375558103 606,230 -12,772 -2.06 50,826 19.68 0.0707
2024-08-14 2024-06-30 13F GILEAD SCIENCES COM 375558103 619,002 77,337 14.28 42,470 7.04 0.0631
2024-05-10 2024-03-31 13F GILEAD SCIENCES COM 375558103 541,665 6,108 1.14 39,677 -8.55 0.0572
2024-01-30 2023-12-31 13F GILEAD SCIENCES COM 375558103 535,557 43,630 8.87 43,385 20.37 0.0654
2023-10-25 2023-09-30 13F GILEAD SCIENCES COM 375558103 491,927 13,090 2.73 36,043 -1.88 0.0606
2023-08-03 2023-06-30 13F GILEAD SCIENCES COM 375558103 478,837 74,710 18.49 36,734 9.55 0.0557
2023-04-24 2023-03-31 13F GILEAD SCIENCES COM 375558103 404,127 -77,024 -16.01 33,530 -18.83 0.0518
2023-02-14 2022-12-31 13F GILEAD SCIENCES COM 375558103 481,151 -116,844 -19.54 41,307 11.97 0.0690
2022-10-07 2022-09-30 13F Gilead Sciences Common Stock 375558103 597,995 8,761 1.49 36,890 1.29 0.0634
2022-08-10 2022-06-30 13F GILEAD SCIENCES COM 375558103 589,234 26,673 4.74 36,421 8.90 0.0583
2022-05-13 2022-03-31 13F GILEAD SCIENCES COM 375558103 562,561 32,327 6.10 33,444 -13.13 0.0448
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 530,234 23,035 4.54 38,500 8.67 0.0519
2021-11-08 2021-09-30 13F GILEAD SCIENCES COM 375558103 507,199 71,189 16.33 35,428 18.00 0.0502
2021-08-11 2021-06-30 13F GILEAD SCIENCES COM 375558103 436,010 22,080 5.33 30,024 12.23 0.0418
2021-05-14 2021-03-31 13F GILEAD SCIENCES COM 375558103 413,930 215,664 108.78 26,752 131.60 0.0408
2021-02-10 2020-12-31 13F GILEAD SCIENCES COM 375558103 198,266 65,296 49.11 11,551 37.48 0.0249
2020-11-13 2020-09-30 13F GILEAD SCIENCES COM 375558103 132,970 -59,026 -30.74 8,402 -43.12 0.0209
2020-08-13 2020-06-30 13F GILEAD SCIENCES COM 375558103 191,996 16,800 9.59 14,772 12.78 0.0395
2020-05-14 2020-03-31 13F GILEAD SCIENCES COM 375558103 175,196 -213,223 -54.90 13,098 -48.10 0.0421
2020-02-13 2019-12-31 13F GILEAD SCIENCES COM 375558103 388,419 -88,055 -18.48 25,239 -16.42 0.0621
2019-11-14 2019-09-30 13F GILEAD SCIENCES COM 375558103 476,474 269,974 130.74 30,199 116.46 0.0794
2019-08-23 2019-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 206,500 -239,441 -53.69 13,951 -51.88 0.0360
2019-08-14 2019-06-30 13F GILEAD SCIENCES COM 375558103 206,500 -239,441 13,951
2019-05-15 2019-03-31 13F GILEAD SCIENCES COM 375558103 445,941 -81,447 -15.44 28,991 -12.12 0.0700
2019-02-06 2018-12-31 13F GILEAD SCIENCES COM 375558103 527,388 -98,354 -15.72 32,988 -31.72 0.0867
2018-11-15 2018-09-30 13F GILEAD SCIENCES COM 375558103 625,742 -121,729 -16.29 48,314 -8.76 0.1175
2018-08-13 2018-06-30 13F GILEAD SCIENCES COM 375558103 747,471 203,371 37.38 52,951 29.09 0.1351
2018-05-14 2018-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 544,100 -213,308 -28.16 41,020 -24.40 0.1046
2018-05-14 2018-03-31 13F GILEAD SCIENCES COM 375558103 544,100 41,020
2018-02-13 2017-12-31 13F GILEAD SCIENCES COM 375558103 757,408 312,671 70.30 54,261 50.59 0.1310
2017-11-13 2017-09-30 13F GILEAD SCIENCES COM 375558103 444,737 -3,987 -0.89 36,033 13.45 0.1943
2017-08-14 2017-06-30 13F GILEAD SCIENCES COM 375558103 448,724 178,023 65.76 31,761 72.75 0.1768
2017-05-25 2017-03-31 13F/A-1 GILEAD SCIENCES COM 375558103 270,701 -6,669 -2.40 18,386 -7.43 0.1075
2017-05-12 2017-03-31 13F GILEAD SCIENCES COM 375558103 270,701 18,386
2017-02-14 2016-12-31 13F GILEAD SCIENCES COM 375558103 277,370 3,831 1.40 19,862 -8.22 0.1190
2016-11-15 2016-09-30 13F GILEAD SCIENCES COM 375558103 273,539 -180,013 -39.69 21,642 -42.80 0.1351
2016-08-12 2016-06-30 13F GILEAD SCIENCES COM 375558103 453,552 82,637 22.28 37,835 11.04 0.2137
2016-05-12 2016-03-31 13F GILEAD SCIENCES COM 375558103 370,915 23,865 6.88 34,072 -2.98 0.3091
2016-02-12 2015-12-31 13F GILEAD SCIENCES COM 375558103 347,050 74,498 27.33 35,118 31.22 0.2179
2015-11-13 2015-09-30 13F GILEAD SCIENCES COM 375558103 272,552 -17,318 -5.97 26,762 -21.14 0.1624
2015-08-13 2015-06-30 13F GILEAD SCIENCES COM 375558103 289,870 -29,582 -9.26 33,938 8.26 0.1840
2015-05-13 2015-03-31 13F GILEAD SCIENCES COM 375558103 319,452 -13,540 -4.07 31,348 -0.13 0.1653
2015-02-11 2014-12-31 13F GILEAD SCIENCES COM 375558103 332,992 89,707 36.87 31,388 21.20 0.1602
2014-11-12 2014-09-30 13F GILEAD SCIENCES COM 375558103 243,285 -290,329 -54.41 25,898 -41.46 0.1298
2014-08-11 2014-06-30 13F GILEAD SCIENCES COM 375558103 533,614 -81,144 -13.20 44,242 1.56 0.2058
2014-05-14 2014-03-31 13F GILEAD SCIENCES COM 375558103 614,758 197,775 47.43 43,562 39.11 0.2136
2014-02-11 2013-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 416,983 -192,358 -31.57 31,315 -18.26 0.1582
2014-02-03 2013-12-31 13F GILEAD SCIENCES COM 375558103 416,983 31,315
2013-11-12 2013-09-30 13F GILEAD SCIENCES COM 375558103 609,341 -123,905 -16.90 38,309 1.90 0.1939
2013-08-20 2013-06-30 13F/A-1 GILEAD SCIENCES COM 375558103 733,246 733,246 37,594 0.1793
2013-08-09 2013-06-30 13F GILEAD SCIENCES COM 375558103 733,246 37,594 0.1799
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-13 2025-09-30 13F GILEAD SCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-13 2025-06-30 13F GILEAD SCIENCES COM Put 12,600 3 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.